WAVEMAN · COMPANY

CLGN · Collplant Biotechnologies Ltd

LIVE

TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475

← ALL COMPANIES

CLGN

Name: CollPlant Biotechnologies Ltd (CLGN) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

CollPlant Biotechnologies Ltd

MEDICAL DEVICES · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · CIK 0001631487

SEC FILINGS☆ WATCH

INSIDER NET · 180D

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+360.4%

XBRL, annual

NET MARGIN

-484.6%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

no Form 4 purchases or sales on file

CONGRESS

no member of Congress has reported trading it

FUNDS

5 funds added or opened last quarter

below 96% of Medical Devices

REVENUE

+360.4% year over year

more than 98% of Medical Devices

MARGIN

-484.6% net margin

below 93% of Medical Devices

BUYBACKS

no share repurchases reported

SHORT

0.1% of shares outstanding short · 1.0 days to cover · settled 2026-07-31

below 90% of Medical Devices

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows 5 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for CollPlant Biotechnologies Ltd in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER

FILED

VALUE

no insider purchases or sales on record

0 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

PINNACLE ASSOCIATES LTD

731,663.0 sh

$255.3K

VILLERE ST DENIS J & CO LLC

606,400.0 sh

$211.6K

BROWN ADVISORY INC

104,731.0 sh

$36.5K

RENAISSANCE TECHNOLOGIES LLC

61,500.0 sh

$21.5K

Pathstone Holdings, LLC

57,000.0 sh

$19.9K

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$2.4M	$515.0K	$11.0M	$299.0K
GROSS PROFIT	$1.5M	$-1.1M	$9.0M	$-101.0K
OPERATING INCOME	$-11.5M	$-17.3M	$-7.5M	$-17.1M
NET INCOME	$-11.5M	$-16.6M	$-7.0M	$-16.9M
EPS (DILUTED)	-0.94	-1.45	-0.62	-1.53
OPERATING CASH FLOW	$-9.4M	$-14.1M	$-2.8M	$-13.7M
CASH	$5.6M	$11.9M	$26.7M	$29.7M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE